JP2013507397A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507397A5
JP2013507397A5 JP2012533376A JP2012533376A JP2013507397A5 JP 2013507397 A5 JP2013507397 A5 JP 2013507397A5 JP 2012533376 A JP2012533376 A JP 2012533376A JP 2012533376 A JP2012533376 A JP 2012533376A JP 2013507397 A5 JP2013507397 A5 JP 2013507397A5
Authority
JP
Japan
Prior art keywords
thiazolidine
benzylidene
dione
pharmaceutical composition
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012533376A
Other languages
English (en)
Japanese (ja)
Other versions
JP5847085B2 (ja
JP2013507397A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052151 external-priority patent/WO2011044548A1/en
Publication of JP2013507397A publication Critical patent/JP2013507397A/ja
Publication of JP2013507397A5 publication Critical patent/JP2013507397A5/ja
Application granted granted Critical
Publication of JP5847085B2 publication Critical patent/JP5847085B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012533376A 2009-10-09 2010-10-11 チアゾリジンジオンエネルギー制限模倣剤 Expired - Fee Related JP5847085B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25004509P 2009-10-09 2009-10-09
US61/250,045 2009-10-09
US30488110P 2010-02-16 2010-02-16
US61/304,881 2010-02-16
PCT/US2010/052151 WO2011044548A1 (en) 2009-10-09 2010-10-11 Thiazolidinedione energy restriction-mimetic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015036155A Division JP2015098492A (ja) 2009-10-09 2015-02-26 チアゾリジンジオンエネルギー制限模倣剤

Publications (3)

Publication Number Publication Date
JP2013507397A JP2013507397A (ja) 2013-03-04
JP2013507397A5 true JP2013507397A5 (enExample) 2013-11-14
JP5847085B2 JP5847085B2 (ja) 2016-01-20

Family

ID=43855337

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012533376A Expired - Fee Related JP5847085B2 (ja) 2009-10-09 2010-10-11 チアゾリジンジオンエネルギー制限模倣剤
JP2015036155A Withdrawn JP2015098492A (ja) 2009-10-09 2015-02-26 チアゾリジンジオンエネルギー制限模倣剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015036155A Withdrawn JP2015098492A (ja) 2009-10-09 2015-02-26 チアゾリジンジオンエネルギー制限模倣剤

Country Status (6)

Country Link
US (1) US8383656B2 (enExample)
EP (1) EP2488027A4 (enExample)
JP (2) JP5847085B2 (enExample)
CN (1) CN102638980A (enExample)
CA (1) CA2777406A1 (enExample)
WO (1) WO2011044548A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012153775A1 (ja) * 2011-05-10 2012-11-15 国立大学法人神戸大学 Ras機能阻害作用を有するチオキソチアゾリジン誘導体
US9174951B2 (en) * 2012-03-28 2015-11-03 Ohio State Innovation Foundation Glucose transporter inhibitors
AU2014207272A1 (en) * 2013-01-18 2015-07-30 Neal D. Andruska Estrogen receptor inhibitors
CN105315223B (zh) * 2015-11-06 2017-08-25 河南大学 一种高立体和高对映选择性噻唑烷二酮类化合物、其制备方法及应用
CN111675673B (zh) * 2020-06-22 2022-06-24 郑州大学 3,4-二羟基肉桂酸酯类衍生物及其制备方法和应用
US12150935B1 (en) 2024-04-16 2024-11-26 Imam Mohammad Ibn Saud Islamic University 3-(3-(1,3-dioxoisoindolin-2-yl) propyl)-5-(4-fluorobenzylidene) thiazolidine-2,4-dione as a potential antitumor and apoptotic inducer

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1003083A (en) 1961-01-21 1965-09-02 Toshiyasu Kasai Novel 4-alkoxynaphthalimides
GB962019A (en) 1961-04-12 1964-06-24 Mitsubishi Chem Ind Naphthalimide optical whitening agents
JPS4957048A (enExample) 1972-10-04 1974-06-03
JPS5697277A (en) 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
US4814366A (en) 1986-10-07 1989-03-21 Mitsubishi Chemical Industries Limited Thermoplastic polyester resin composition
JPS6424852A (en) 1987-07-21 1989-01-26 Mitsubishi Chem Ind Polyamide resin composition
DE68915844T2 (de) 1988-03-29 1994-10-06 Mitsubishi Chem Ind Thermoplastische Polyesterharzmischung und daraus hergestellte Formgegenstände.
JP2792111B2 (ja) 1989-06-16 1998-08-27 三菱化学株式会社 ポリエステル樹脂成形体の製造方法
EP0454501B1 (en) 1990-04-27 2001-09-05 Sankyo Company Limited Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides
JP3020353B2 (ja) 1992-07-21 2000-03-15 ポーラ化成工業株式会社 化粧料
US6046222A (en) 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
JPH07247978A (ja) 1994-03-14 1995-09-26 Hitachi Ltd 冷媒ポンプ
GB9409466D0 (en) 1994-05-12 1994-06-29 Ciba Geigy Ag Textile treatment
PT682145E (pt) 1994-05-12 2005-01-31 Ciba Sc Holding Ag Trtamento textil
US5801173A (en) 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
JP2817708B2 (ja) 1996-05-29 1998-10-30 日本電気株式会社 有機非線形光学材料及び有機非線形光学素子
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
CN1384825A (zh) 1999-08-31 2002-12-11 马克西亚药品公司 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
DE10353328A1 (de) 2003-11-14 2005-06-16 Basf Ag Verwendung von Naphthalin-1,8-dicarbonsäuremonoimiden
EA200700262A1 (ru) * 2004-07-14 2007-08-31 Янссен Фармацевтика Н.В. Арилидены для лечения заболеваний, опосредуемых эстроген-родственным рецепторам альфа
US7566787B2 (en) 2004-12-22 2009-07-28 The Ohio State University Small molecule cyclin D1 ablative agents
WO2006069186A2 (en) 2004-12-22 2006-06-29 The Ohio State Research Foundation Small molecule bcl-xl/bcl-2 binding inhibitors
US7608715B2 (en) 2005-11-21 2009-10-27 Sabic Innovative Plastics Ip B.V. Fluorescent brighteners, methods of preparation thereof, fluorescent brightener compositions, and methods of preparation and uses thereof
JP2010520306A (ja) * 2007-03-07 2010-06-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ エストロゲン関連受容体−αモジュレーターとしての置換フェノキシチアゾリジンジオン
GB0715284D0 (en) * 2007-08-06 2007-09-12 Medical Res Council Crystal structure of ampk and uses thereof
CA2743756A1 (en) * 2007-11-15 2009-05-22 Musc Foundation For Research Development Inhibitors of pim protein kinases, compositions, and methods for treating cancer
EP2254576B1 (en) * 2008-02-22 2013-08-28 The Ohio State University Research Foundation Androgen receptor-ablative agents

Similar Documents

Publication Publication Date Title
RU2500673C2 (ru) Гетероциклические ингибиторы мек и способы их применения
RU2501791C2 (ru) Производное триазола или его соль
JP2005525371A5 (enExample)
RU2485131C2 (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой и содержащие их противогрибковые средства
JP2014528450A5 (enExample)
JP2019517455A5 (enExample)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
NZ590859A (en) Thiazolidinedione compounds useful in the treatment of pim kinase related conditions and diseases
JP2014523400A5 (enExample)
JP2010506825A5 (enExample)
JP2016512844A5 (enExample)
JP2013544276A5 (enExample)
NZ609955A (en) Sgc stimulators
JP2014528486A5 (enExample)
JP2013514367A5 (enExample)
CA2607848A1 (en) 3-substituted (3-phenyl)-propionic acid derivatives for the treatment of metabolic disorders
PE20120430A1 (es) Dicianopiridinas alquilamino-sustituidas
JP2010540462A5 (enExample)
JP2010516765A5 (enExample)
RU2013123275A (ru) Пиперидин-4-илазетидиндиамиды как ингибиторы моноацилглицеринлипазы
JP2009529059A5 (enExample)
MX2009003535A (es) Formas cristalinas de un compuesto de tiazolidinodiona, y metodos de fabricacion de las mismas.
SG10201407430TA (en) N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
JP2006516251A5 (enExample)
RU2014114120A (ru) Производные бензойной кислоты в качестве ингибиторов эукариотического фактора инициации трансляции 4е